Monopar Therapeutics Inc
NASDAQ:MNPR
Income Statement
Earnings Waterfall
Monopar Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-8.8m
USD
|
Operating Income
|
-8.8m
USD
|
Other Expenses
|
429k
USD
|
Net Income
|
-8.4m
USD
|
Income Statement
Monopar Therapeutics Inc
Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||
Operating Expenses |
(17)
|
(17)
|
(17)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(7)
|
(7)
|
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(10)
|
(10)
|
(9)
|
|
Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
Research & Development |
(15)
|
(16)
|
(16)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
(7)
|
(8)
|
(8)
|
(7)
|
(7)
|
(6)
|
|
Operating Income |
(17)
N/A
|
(17)
-3%
|
(17)
-1%
|
(3)
+82%
|
(3)
-6%
|
(4)
-16%
|
(4)
-2%
|
(4)
-2%
|
(4)
-7%
|
(4)
+6%
|
(5)
-13%
|
(5)
-19%
|
(7)
-19%
|
(7)
-12%
|
(8)
-9%
|
(9)
-10%
|
(9)
-5%
|
(10)
-6%
|
(10)
-7%
|
(10)
+0%
|
(11)
-2%
|
(11)
-1%
|
(10)
+4%
|
(10)
+3%
|
(9)
+10%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(17)
N/A
|
(17)
-3%
|
(17)
-1%
|
(3)
+82%
|
(3)
-6%
|
(4)
-15%
|
(4)
-2%
|
(4)
-3%
|
(4)
-8%
|
(4)
+6%
|
(4)
-14%
|
(5)
-20%
|
(6)
-17%
|
(7)
-13%
|
(8)
-9%
|
(9)
-11%
|
(9)
-6%
|
(10)
-6%
|
(10)
-7%
|
(10)
+1%
|
(11)
-2%
|
(10)
+0%
|
(10)
+5%
|
(9)
+5%
|
(8)
+11%
|
|
Net Income | ||||||||||||||||||||||||||
Income from Continuing Operations |
(17)
|
(17)
|
(17)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(10)
|
(10)
|
(9)
|
(8)
|
|
Net Income (Common) |
(17)
N/A
|
(17)
-3%
|
(17)
-1%
|
(3)
+82%
|
(3)
-6%
|
(4)
-15%
|
(4)
-2%
|
(4)
-3%
|
(4)
-8%
|
(4)
+6%
|
(4)
-14%
|
(5)
-20%
|
(6)
-17%
|
(7)
-13%
|
(8)
-9%
|
(9)
-11%
|
(9)
-6%
|
(10)
-6%
|
(10)
-7%
|
(10)
+1%
|
(11)
-2%
|
(10)
+0%
|
(10)
+5%
|
(9)
+5%
|
(8)
+11%
|
|
EPS (Diluted) |
-1.59
N/A
|
-1.64
-3%
|
-1.66
-1%
|
-0.29
+83%
|
-0.31
-7%
|
-0.36
-16%
|
-0.37
-3%
|
-0.38
-3%
|
-0.41
-8%
|
-0.38
+7%
|
-0.43
-13%
|
-0.48
-12%
|
-0.58
-21%
|
-0.58
N/A
|
-0.61
-5%
|
-0.67
-10%
|
-0.73
-9%
|
-0.77
-5%
|
-0.82
-6%
|
-0.81
+1%
|
-0.83
-2%
|
-0.82
+1%
|
-0.73
+11%
|
-0.67
+8%
|
-0.61
+9%
|